跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APIXABAN TEVAGEN 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APIXABAN TEVAGEN 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
APIXABAN TEVAGEN 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 25, 2022
Approval ID
466ec9566f5ba303
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
466ec9566f5ba303
Drug Cima Aemps Name
APIXABAN TEVAGEN 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88155
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2022-11-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Teva Pharma S.L.U.
Active Ingredients
APIXABAN
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 25, 2022
Approval ID
466ec9566f5ba303
Type
Standard
Back to CIMA-AEMPS Approvals